Generic drug tariffs set to skyrocket in 2028. Consumers could feel impact

comes at a cost

Vontobel analyst Stefan Schneider said the United States seeks to reverse the shift of generic drug production to lower-cost countries, but bringing manufacturing back would likely raise generic drug prices in the United States, Reuters reported.

Schneider added that any new rules would predominantly affect China and India, where most continue reading …